Study of Intensive Care Units in India (INDICAPS)

Indian Intensive Care Case Mix and Practice Patterns Study

There is scant data on the casemix and practices in Indian intensive care units (ICUs). Most of the available data comes from single centre studies. There is a dire need to have data from Indian ICUs to reflect the vast spectrum of critical care illness, services and practices. INDICAPS planned to collect data of all patients in the ICU on one particular day, and four such days spread throughout a one-year period were selected: the second Wednesday of July and October this year, i.e. July 14 and October 13, 2010 and the second Wednesday of January and April next year, i.e. January 12 and April 13, 2011. As many ICUs all over the country as possible were asked to participate. The investigators aimed to gather information about ICUs, patients in ICUs, the types and severity of illness, monitoring and therapeutic modalities used, types of infections,mortality rates, etc.

Study Overview

• Status: Completed
• Conditions: Critical Illness

Detailed Description

The following information will be analysed:

Case-mix, severity of illness, prevalence of infection, hemodynamic monitoring and therapy, mechanical ventilation practices, nutrition and outcome

• Seasonal and regional variations in the above
• Epidemiology and variations in antibiotic use
• Patterns of microorganisms and outcome
• Prevalence and outcome of specific tropical febrile illnesses, including malaria, dengue fever, leptospirosis, scrub typhus
• Prevalence and outcome of toxins and poisonings
• Relation of ICU and hospital organizational issues to prevalence of infection and outcome
• Organisation of intensive care services
• End of life - Ethical decisions

• Study Type: Observational
• Enrollment (Actual): 4236

Contacts and Locations

Study Locations

• India
  • Maharashtra
    • Mumbai, Maharashtra, India, 400058
      • Tata Memorial Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: ADULT; OLDER_ADULT; CHILD
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

All patients present in the ICU July 14, 2010, October 13, 2010, January 12, 2011 and April 13, 2011

Description

Inclusion Criteria:

• All patients present in the ICU July 14, 2010, October 13, 2010, January 12, 2011 and April 13, 2011

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
ICU patients; All patients present in the ICU on the selected days

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
All cause mortality	30-days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
ICU Length of stay	Stay in ICU till 30 days	30 days
Hospital length of stay	Stay in hospital till 30 days	30 days
Hospital survival	Survival at hospital discharge or at 30 days	30 days

Collaborators and Investigators

• Sponsor: Indian Society of Critical Care Medicine
• Investigators: Study Chair: Jigeeshu Divatia, MD, Indian Society of Critical Care Medicine

Study record dates

Study Major Dates

• Study Start: July 1, 2010
• Primary Completion (Actual): May 1, 2011
• Study Completion (Actual): May 1, 2011

Study Registration Dates

• First Submitted: June 28, 2011
• First Submitted That Met QC Criteria: June 28, 2011
• First Posted (Estimate): June 29, 2011

Study Record Updates

• Last Update Posted (Estimate): June 29, 2011
• Last Update Submitted That Met QC Criteria: June 28, 2011
• Last Verified: April 1, 2011

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Pathologic Processes; Disease Attributes; Critical Illness
• Other Study ID Numbers: ISCCM01